VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
AUTL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
AUTLAutolus Therapeutics plc
$1.28$341M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAUTLQuarterly Financials

Autolus Therapeutics plc (AUTL) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Autolus Therapeutics plc (AUTL) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

AUTL Income Statement

Quarterly statement

AUTL Income Statement

Autolus Therapeutics plc (AUTL) annual income statement — 11-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue45.69M26.22M24.25M21.19M20.92M8.98M29K0010.09M0406K01.29M3.83M2.37M00180K236K
Revenue Growth %118.37%191.89%83534.17%---10.99%--100%-681.04%-100%-82.86%--2025%903.81%-100%-100%-55.45%-65.29%
Cost of Goods Sold20.47M24.57M25.29M28.64M24.45M17.95M138.3M1.22M01.81M1.77M1.52M01.9M1.71M37.63M02.07M39.63M32.29M
COGS % of Revenue44.8%93.71%104.29%135.15%116.83%199.86%476910.34%--17.9%-375.62%-146.98%44.81%1588.52%--22019.44%13683.05%
Gross Profit25.22M1.65M-1.04M-7.45M-3.52M-8.97M-138.28M-1.22M08.29M-1.77M-1.12M0-607K2.11M-35.26M0-2.07M-39.45M-32.06M
Gross Margin %55.2%6.29%-4.29%-35.15%-16.83%-99.86%-476810.34%--82.1%--275.62%--46.98%55.19%-1488.52%---21919.44%-13583.05%
Gross Profit Growth %816.1%118.4%99.25%-511.58%--208.26%-7690.14%-8.85%-1464.91%-184.08%96.83%-70.63%105.35%-10%100%93.21%-2.95%2.46%
Operating Expenses69.06M61.16M71.32M64.17M57.7M56.27M103.15M67.65M58.93M47.04M39.11M42.93M44.35M34.77M32.41M45.86M46.48M39.88M47.33M40.59M
OpEx % of Revenue151.15%233.29%294.06%302.78%275.75%626.45%355693.1%--466.18%-10573.65%-2691.41%847.27%1935.96%--26292.22%17199.58%
Selling, General & Admin41.16M39.95M35.74M36.28M30.27M29.53M42.48M27.33M21.9M16.37M13.95M10.61M11.12M7.38M5.7M8.23M8.27M5.92M7.59M8.3M
SG&A % of Revenue90.09%152.39%147.36%171.18%144.65%328.81%146479.31%--162.23%-2613.55%-571.59%148.97%347.45%--4217.22%3516.53%
Research & Development27.9M21.21M35.58M27.89M27.43M26.73M50.53M40.32M36.61M30.67M25.16M32.32M33.23M27.39M26.71M37.63M38.21M33.96M39.73M32.29M
R&D % of Revenue61.06%80.9%146.7%131.6%131.1%297.64%174241.38%--303.94%-7960.1%-2119.81%698.3%1588.52%--22075%13683.05%
Other Operating Expenses0010001000K0414K00000000000
Operating Income-43.84M-59.51M-72.36M-71.62M-61.22M-65.24M-241.43M-68.87M-58.93M-38.76M-40.89M-44.05M-44.35M-35.38M-30.3M-81.13M-46.48M-41.95M-86.78M-72.65M
Operating Margin %-95.95%-226.99%-298.35%-337.93%-292.58%-726.31%-832503.45%---384.07%--10849.26%--2738.39%-792.08%-3424.48%---48211.67%-30782.63%
Operating Income Growth %28.39%8.77%70.03%-3.99%-3.88%-68.32%-490.49%-56.35%-32.86%-9.54%-34.95%45.7%4.58%15.66%65.09%-11.67%33.46%40.01%-0.87%4.8%
EBITDA-41.19M-56.81M-69.73M-68.24M-56.91M-62.96M-239.35M-66.93M-54.74M-36.95M-39.11M-42.67M-42.84M-33.48M-28.58M-79.34M-44.56M-39.88M-84.77M-70.2M
EBITDA Margin %-90.15%-216.69%-287.52%-321.97%-271.98%-700.96%-825341.38%---366.18%--10509.61%--2591.41%-747.27%-3349.05%---47092.78%-29745.34%
EBITDA Growth %27.62%9.76%70.87%-1.95%-3.95%-70.39%-511.97%-56.87%-27.78%-10.36%-36.83%46.22%3.86%16.05%66.28%-13.02%34.09%41.58%-0.36%6.21%
D&A (Non-Cash Add-back)2.65M2.7M2.63M3.38M4.31M2.28M2.08M1.94M4.18M1.81M1.77M1.38M1.51M1.9M1.71M1.79M1.92M2.07M2.01M2.45M
EBIT-35.97M-59.63M-68.58M-68.07M-47.52M-57.79M-75.86M-67.65M-48.05M-33.43M-34.68M-42.52M-40.49M-34.92M-23.14M-43.49M-47.72M-40.9M-47.05M-40.35M
Net Interest Income-797K-8.64M-19.58M-6.14M12.06M-4.01M38.28M-2.37M-518K-12.34M-27.12M-1.37M-1.62M-1.46M-2.03M-1.69M-1.72M-1.76M-956K28K
Interest Income1.88M2.47M3.22M4.38M12.06M6.14M7.45M8.32M9.66M6.93M3.01M3.65M3.4M3.45M1.43M165K89K28K149K28K
Interest Expense2.67M11.11M22.8M10.52M010.14M-30.84M10.69M10.17M19.27M30.13M5.01M5.02M4.91M3.46M1.85M1.81M1.79M1.1M0
Other Income/Expense5.19M-11.22M-19.02M-6.96M13.7M-2.7M215.28M-13.2M708K-13.94M-23.92M-1.82M-1.16M-4.45M3.71M32.21M-3.05M-736K38.69M33.27M
Pretax Income-38.65M-70.73M-91.38M-78.59M-47.52M-67.94M-26.14M-82.07M-58.22M-52.7M-64.81M-45.87M-45.51M-39.83M-26.59M-48.92M-49.53M-42.69M-48.09M-39.38M
Pretax Margin %-84.58%-269.8%-376.78%-370.79%-227.12%-756.36%-90151.72%---522.23%--11298.03%--3082.43%-695.22%-2064.96%---26717.78%-16684.75%
Income Tax465K861.55K-1.18M532K397K2.23M1.46M22K51K-8K12.36M-21K40K-14K359K-6.15M-7.47M-5.62M-6.43M-5.38M
Effective Tax Rate %-1.2%-1.22%1.29%-0.68%-0.84%-3.28%-5.59%-0.03%-0.09%0.02%-19.07%0.05%-0.09%0.04%-1.35%12.58%15.09%13.18%13.36%13.68%
Net Income-39.11M-71.6M-90.2M-79.12M-47.92M-70.16M-27.61M-82.09M-58.27M-52.69M-77.17M-45.85M-45.55M-39.81M-26.95M-42.77M-42.06M-37.06M-41.67M-33.99M
Net Margin %-85.6%-273.09%-371.91%-373.3%-229.02%-781.13%-95193.1%---522.15%--11292.86%--3081.35%-704.6%-1805.28%---23147.78%-14402.97%
Net Income Growth %18.38%-2.05%-226.75%3.63%17.77%-33.16%64.23%-79.05%-27.92%-32.35%-186.34%-7.21%-8.3%-7.42%35.32%-25.82%-26.79%-11.41%2.79%8.91%
Net Income (Continuing)-39.11M-71.6M-90.2M-79.12M-47.92M-70.16M-27.61M-82.09M-58.27M-52.69M-77.17M-45.85M-45.55M-39.81M-26.95M-42.77M-42.06M-37.06M-41.67M-33.99M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.15-0.27-0.34-0.30-0.18-0.26-0.10-0.31-0.22-0.24-0.44-0.26-0.26-0.23-0.23-0.47-0.46-0.41-0.57-0.47
EPS Growth %16.67%-3.85%-240%3.23%18.18%-8.33%77.27%-19.23%15.38%-4.35%-91.3%44.68%43.48%43.9%59.65%0%2.13%22.64%17.39%34.72%
EPS (Basic)-0.15-0.27-0.34-0.30-0.18-0.26-0.10-0.31-0.22-0.24-0.44-0.26-0.26-0.23-0.23-0.47-0.46-0.41-0.57-0.47
Diluted Shares Outstanding266.16M266.14M266.14M266.14M266.14M266.13M266.13M266.08M266.03M222.17M174.03M173.98M173.86M173.83M117.18M91.24M90.93M90.91M72.9M72.9M
Basic Shares Outstanding266.16M266.14M266.14M266.14M266.14M266.13M266.13M266.08M266.03M222.17M174.03M173.98M173.86M173.83M117.18M90.99M90.93M90.91M72.9M72.9M
Dividend Payout Ratio--------------------